What is Interpharm Holdings, Inc. (IPAH)?

Interpharm Holdings, Inc. (IPAH) is a stock in the Healthcare sector, Medical - Pharmaceuticals industry. View full analysis on Stocks360.

What is the current price of IPAH?

The current price of IPAH is $0.00. Prices are updated in real time on Stocks360.

What is IPAH's price-to-earnings (PE) ratio?

IPAH's trailing twelve-month PE ratio is -0.00, based on current price and earnings per share data available on Stocks360.

What is IPAH's market capitalization?

IPAH's market capitalization is $667.00, placing it in the small-cap tier.

Interpharm Holdings, Inc. (IPAH)

Stock analysis · OTC · Healthcare · Medical - Pharmaceuticals

$0.00

Market Cap

$667.00

PE (TTM)

-0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-1.65

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

500.00

Interpharm Holdings, Inc. (IPAH) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $667.00. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-27 · $0.00 2026-10-23 · $0.00 (-99.76%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Interpharm Holdings, Inc.

Interpharm Holdings, Inc. specializes in the formulation, manufacturing, and commercialization of generic pharmaceuticals, encompassing both prescription-strength and over-the-counter varieties. The company's medicinal products are supplied to a wide array of clients, including significant retail chains, wholesale distributors, managed healthcare organizations, and nationwide distribution networks. Established in 1984, the firm maintains its principal operations in Hauppauge, New York.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.00×
P/S (TTM)	0.00×
P/B	0.00×
PEG	0.00×
P/FCF (TTM)	-0.00×
EV / EBITDA	-3.23×
EV / Sales	0.35×
Earnings Yield	-2154746.94%
Free Cash Flow Yield	-3314542.73%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$26.47M
Revenue (TTM)	$75.59M
Net Income (TTM)	-$14.37M
Free Cash Flow (TTM)	-$22.11M
Net Debt	$26.47M
Working Capital	$1.53M
Gross Margin	28.66%
Operating Margin	-14.21%
Net Margin	-18.60%
Return on Equity	-82.09%
Return on Invested Capital	-19.23%